(Q41590380)

4 October 2017

Kick-starting the cancer-immunity cycle by targeting CD40. (English)

1 reference

4 October 2017

P Ellmark

1

1 reference

4 October 2017

S M Mangsbo

2

1 reference

4 October 2017

C Furebring

3

1 reference

4 October 2017

T H Tötterman

4

1 reference

4 October 2017

P Norlén

5

1 reference

4 October 2017

16 March 2015

1 reference

4 October 2017

1 reference

4 October 2017

4

1 reference

4 October 2017

7

1 reference

4 October 2017

e1011484

1 reference

Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment

4 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Immune modulation for cancer therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Intratumoral immunization: a new paradigm for cancer therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Oncology meets immunology: the cancer-immunity cycle

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Agonistic CD40 antibodies and cancer therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485842

10.1080/2162402X.2015.1011484

6 June 2018

Identifiers

DOI

1 reference

4 October 2017

1 reference

4 October 2017

PubMed publication ID

26140231

1 reference